Overview

A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.
Phase:
Phase 2
Details
Lead Sponsor:
Cantex Pharmaceuticals
Chimerix
Treatments:
Heparin